Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1600 1625 1635 1636 1674 1682
This examiner grants 68% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 17417022 | Beta-Galactosidase Alpha Peptide as a Non-Antibiotic Selection Marker and Uses Thereof | Final Rejection | Janssen Biotech, Inc. |
| 17913100 | MICRORNAS FOR THE PREVENTION OF CLINICAL VENOUS THROMBOEMBOLIC DISEASE | Non-Final OA | UNIVERSITY OF MASSACHUSETTS |
| 17914307 | BIFUNCTIONAL MOLECULES AND METHODS OF USING THEREOF | Non-Final OA | Flagship Pioneering Innovations VI, LLC |
| 17795943 | DELIVERY OF COMPOSITIONS COMPRISING CIRCULAR POLYRIBONUCLEOTIDES | Final Rejection | Flagship Pioneering Innovations VI, LLC |
| 17780600 | RNA INTERFERENCE-INDUCING NUCLEIC ACID COMPRISING 8-OXOGUANINE, MODIFIED NUCLEIC ACID BINDING TO MICRORNA COMPRISING 8-OXOGUANINE, AND USES THEREOF | Final Rejection | KOREA UNIVERSITY RESEARCH AND BUSINESS FOUNDATION |
| 17612000 | DNA NANOARCHITECTURES FOR PATTERN-RECOGNIZED TARGETING OF DISEASES | Final Rejection | RENSSELAER POLYTECHNIC INSTITUTE |
| 16763827 | COMPOSITIONS AND METHODS FOR EFFICIENT GENOME EDITING | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18417527 | METHODS FOR REACTIVATING GENES ON THE INACTIVE X CHROMOSOME | Non-Final OA | The General Hospital Corporation |
| 18044565 | IMMUNOADJUVANT-BASED HYDROGEL COMPOSITION AND USE THEREOF | Non-Final OA | SOOCHOW UNIVERSITY |
| 18145791 | NUCLEIC ACID MOLECULES FOR REDUCTION OF PAPD5 OR PAPD7 MRNA FOR TREATING HEPATITIS B INFECTION | Final Rejection | HOFFMANN-LA ROCHE INC. |
| 18403862 | METHODS AND COMPOSITIONS FOR TREATING SUBJECTS HAVING OR AT RISK OF DEVELOPING A NON-PRIMARY HYPEROXALURIA DISEASE OR DISORDER | Non-Final OA | Alnylam Pharmaceuticals, Inc. |
| 18007007 | ATXN2 IRNA COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATING OR PREVENTING ATXN2-ASSOCIATED NEURODEGENERATIVE DISEASES | Final Rejection | Alnylam Pharmaceuticals, Inc. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy